Latest news
Loading news…
Immune System Therapeutics
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Sydney, New South Wales, Australia Founded 2001 11-50 employees For Profit
Immune System Therapeutics develops monoclonal antibody technologies for the treatment of blood cancers and other blood disorders.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
1
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 0
- Patents granted
- 1
- Trademarks
- 0
- Top patent class
- a61
- IT spend
- $9M
Company Info
- Founded
- 2001
- Employees
- 11-50
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- HQ
- Sydney, New South Wales, Australia
- Region
- Asia-Pacific (APAC), Australasia
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- -0.6
- Trend (90d)
- -0.8
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Immune System Therapeutics
Loading news…
FAQs about Immune System Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.